JPMorgan keeps EUR 55.20 target for Fresenius stock

Published on 10/26/2026 at 16:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 revenue rose 6.00 percent to EUR 5.864 billion. Fresenius stock costs EUR 46.42 on October 26, 2026, up 0.69 percent versus the Xetra close.

Analyst view and key dates

JPMorgan retained its Overweight rating and EUR 55.20 target on October 26, 2026.
Fresenius reported Q2 2026 revenue of EUR 5.864 billion, up 6.00 percent year over year.
Fresenius stock costs EUR 46.42 at Lang & Schwarz on October 26, 2026 at 4:33 p.m. CEST, plus 0.69 percent versus the EUR 46.10 Xetra close of October 23, 2026.
Fresenius is scheduled to report third-quarter 2026 results on November 4, 2026.

Fresenius, DE000FRE5EN2, Illustration mit AI erstellt.

Fresenius stock (ISIN DE000FRE5EN2) is trading at EUR 46.42 at Lang & Schwarz on October 26, 2026 at 4:33 p.m. CEST, up 0.69 percent versus the Xetra close of October 23, 2026 at EUR 46.10. On October 26, 2026, JPMorgan kept its Overweight rating and EUR 55.20 price target, according to Borse Online. Compared with the Lang & Schwarz price on October 26, 2026 at 4:33 p.m. CEST, the target is 18.91 percent higher.

Q2 growth supports the outlook

For the second quarter of 2026, Fresenius reported revenue of EUR 5.864 billion, up 6.00 percent year over year. Core net income reached EUR 470.00 million, compared with EUR 412.00 million in the second quarter of 2025, while core earnings per share rose to EUR 0.83 from EUR 0.73. These figures were reported before special items in the company's Q2 2026 investor materials, available from Fresenius.

Stock remains below its yearly high

The Xetra session range was EUR 45.97 to EUR 46.45 on October 26, 2026 at 9:55 a.m. CEST. The 52-week range was EUR 35.11 to EUR 52.96 as of October 26, 2026, leaving the Lang & Schwarz price 12.35 percent below the high. Trading volume stood at 226,247 shares at 5:23 p.m. CEST.

Valuation and reporting date

Fresenius had a market capitalization of EUR 26.1 billion and a price-to-earnings ratio of 16.89 as of October 26, 2026. The company is scheduled to publish third-quarter 2026 results on November 4, 2026, a date cited in the JPMorgan note carried by Borse Online. JPMorgan expects Fresenius revenue to be 1.60 percent above consensus for that quarter, while adjusted operating profit is expected to be in line with consensus.

What comes next on November 4?

The next report will test whether the Q2 pattern of 6.00 percent revenue growth and 10.00 percent constant-currency EBIT growth continued into the third quarter. For investors, the combination of a EUR 55.20 target and a scheduled November 4, 2026 report provides the clearest near-term reference points for the stock.

Fresenius stock stays below its high

The 12.35 percent gap to the 52-week high contrasts with a 0.69 percent daily gain against the Xetra close of EUR 46.10 on October 23, 2026. Fresenius stock was trading at EUR 46.42 at Lang & Schwarz on October 26, 2026 at 4:33 p.m. CEST, plus 0.69 percent versus that Xetra close. The further course of trading is shown by the continuously updated real-time quote of Fresenius stock.